Pavadi Capital’s Pediatrix Medical MD Stock Holding History

Pavadi Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-167,304	Closed	-$2.76M	–	23
2022 Q3	$2.76M	Buy	+167,304	New	+$3.37M	2.64%	21

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Pavadi Capital's MD Position: Q4 2022 in Review

Pavadi Capital sold out of Pediatrix Medical (MD) in Q4 2022, closing a stake of 167,304 shares — an estimated $2.76M sold.

Pavadi Capital first reported a position in MD in Q3 2022 and held it in 1 quarter. The position peaked at $2.76M in Q3 2022. 209 funds tracked by Wall St. Rank hold MD as of Q4 2022.

Pavadi Capital reported no remaining Pediatrix Medical position as of Q4 2022 after selling out during the quarter.
Pavadi Capital sold 167,304 Pediatrix Medical shares in Q4 2022, an estimated $2.76M.
Pavadi Capital first reported a position in Pediatrix Medical in Q3 2022 and held it in 1 quarter.
Pavadi Capital's Pediatrix Medical position peaked at $2.76M in Q3 2022.
209 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2022.

Based on Pavadi Capital's 13F filing for Q4 2022, filed 14 Feb 2023.